VitaSpring Biomedical Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022
For the nine months, sales was USD 1.49 million compared to USD 2.12 million a year ago. Net loss was USD 0.00576 million compared to net income of USD 0.322629 million a year ago.